Venu
Position Trader, Market Leaders, Fundamental/Technical Analysis
Hinge Health is one of the few AI application businesses already showing both strong growth and real profitability, and the market still underestimates what it can become as the AI application layer matures. It uses AI, motion tracking and clinicians to cut surgeries, opioid use and musculoskeletal costs for nearly 3,000 employers and health plans. Revenue grows 50%, gross margins are 85%, and it is profitable and debt-free. Regulation may slow adoption but not stop it; UnitedHealth is a client. x.com x.com x.comÂ
Hinge Health's revenue growth and cash generation strengthen its case as a leading non-tech IPO near all-time highs. The attached portfolio-stock analysis projects 46% revenue growth in 2026 and puts Q2 free cash flow at about $100 million, roughly three times the year-earlier level. It lists further revenue and margin expansion as potential catalysts. x.com x.comÂ
Hinge Health is fine because money has been funneling into healthcare and out of tech, and the raised-guidance catalyst is now behind it. The stock bounced off its 9-day EMA. x.comÂ
Hinge Health is the best name in healthcare information, the hottest industry of the past quarter. Strong new contracts with health plans have boosted its margins significantly, while good cash flow and conservative leverage add a margin of safety. x.comÂ